Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment

J Allergy Clin Immunol. 2005 Oct;116(4):923-4. doi: 10.1016/j.jaci.2005.06.029. Epub 2005 Aug 19.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Anti-Inflammatory Agents, Non-Steroidal / adverse effects
  • Antibodies, Monoclonal / therapeutic use*
  • Diclofenac / adverse effects
  • Female
  • Humans
  • Infliximab
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Skin / immunology
  • Skin / metabolism
  • Skin / pathology
  • Stevens-Johnson Syndrome / genetics
  • Stevens-Johnson Syndrome / immunology
  • Stevens-Johnson Syndrome / pathology
  • Stevens-Johnson Syndrome / therapy*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / genetics
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha
  • Diclofenac
  • Infliximab